Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Multiple-dose Study to Evaluate the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia

NCT02718716 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT02718716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02718716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Multiple-dose Study to Evaluate the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia
Lead sponsor
UCB Biopharma SRL
Phase
Phase 2
Overall status
Completed
Start date
March 2, 2016
Completion date
February 4, 2019
Enrollment
66 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia